DSGN
Design Therapeutics, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +6.7% ·
flujo de acciones +4.7% ·
nuevas posiciones netas +6.2%
· fórmula
Acumulación amplia: acciones en aumento entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 61 | +2 | 14.66M | $212.03M | +5 | −3 |
| Q1 2026 | 61 | +2 | 13.39M | $142.37M | +4 | −2 |
| Q4 2025 | 59 | +1 | 16.55M | $155.25M | +1 | n/a |
| Q3 2025 | 16 | +1 | 10.74M | $80.90M | +1 | n/a |
| Q2 2025 | 12 | -2 | 9.77M | $32.93M | n/a | −2 |
| Q1 2025 | 11 | +2 | 5.33M | $20.59M | +2 | n/a |
| Q4 2024 | 9 | -2 | 5.31M | $32.78M | n/a | −2 |
| Q3 2024 | 10 | -1 | 4.34M | $23.36M | n/a | −1 |
| Q2 2024 | 11 | n/a | 4.24M | $14.20M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 3.34M | +84.8% | $25.15M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 2.04M | -14.7% | $15.39M | 0.0% | ▼ Trim | 2 | SEC ↗ ×9 |
| 3 | The Vanguard Group ✦ (pasivo) | 1.44M | -1.9% | $10.87M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 4 | Fidelity (FMR) ✦ | 740.85K | -22.1% | $5.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasivo) | 695.61K | -12.4% | $5.24M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | State Street Global Advisors ✦ (pasivo) | 634.40K | -11.8% | $4.78M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 554.02K | -34.1% | $4.17M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 373.28K | -4.5% | $2.81M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 9 | Renaissance Technologies ✦ | 274.30K | +2.4% | $2.07M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 10 | Goldman Sachs Group ✦ | 261.44K | n/a | $1.97M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 11 | Morgan Stanley ✦ | 175.99K | n/a | $1.33M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 12 | Millennium Management ✦ | 68.82K | Nuevo | $518,237 | 0.0% | New | 1 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 59.24K | -33.7% | $446,055 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | JPMorgan Chase ✦ | 46.44K | n/a | $349,708 | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 15 | T. Rowe Price ✦ | 16.31K | 0.0% | $123,000 | 0.0% | Held | 6 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 13.66K | -52.4% | $102,890 | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Millennium Management | $518,237 | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 124 tenedores, 37.97M acciones, $395.07M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.